Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119760023 | 11976002 | 3 | F | 20120319 | 20160909 | 20160129 | 20160913 | EXP | CA-ROCHE-1132487 | ROCHE | 39.26 | YR | F | Y | 77.00000 | KG | 20160913 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119760023 | 11976002 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 670 | MG | SOLUTION FOR INFUSION | |||||||
| 119760023 | 11976002 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 396 | MG | SOLUTION FOR INFUSION | |||||||
| 119760023 | 11976002 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 119760023 | 11976002 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 552 | MG | SOLUTION FOR INFUSION | |||||||
| 119760023 | 11976002 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 520 | MG | SOLUTION FOR INFUSION | |||||||
| 119760023 | 11976002 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 119760023 | 11976002 | 7 | C | ENBREL | ETANERCEPT | 1 | 0 | ||||||||||||
| 119760023 | 11976002 | 8 | C | TRIAMZIDE | 2 | 0 | |||||||||||||
| 119760023 | 11976002 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 119760023 | 11976002 | 10 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119760023 | 11976002 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119760023 | 11976002 | 1 | Rheumatoid arthritis |
| 119760023 | 11976002 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119760023 | 11976002 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119760023 | 11976002 | Abdominal distension | |
| 119760023 | 11976002 | Arthralgia | |
| 119760023 | 11976002 | Cellulitis | |
| 119760023 | 11976002 | Drug hypersensitivity | |
| 119760023 | 11976002 | Drug ineffective | |
| 119760023 | 11976002 | Fatigue | |
| 119760023 | 11976002 | Herpes zoster | |
| 119760023 | 11976002 | Infection | |
| 119760023 | 11976002 | Rash | |
| 119760023 | 11976002 | Urticaria | |
| 119760023 | 11976002 | Weight decreased | |
| 119760023 | 11976002 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119760023 | 11976002 | 1 | 20120319 | 20151120 | 0 | |
| 119760023 | 11976002 | 2 | 20130313 | 0 | ||
| 119760023 | 11976002 | 3 | 20130507 | 0 | ||
| 119760023 | 11976002 | 4 | 20130604 | 0 | ||
| 119760023 | 11976002 | 5 | 20140512 | 0 |